NASDAQ$TNGX

Tango Therapeutics Inc · Q4 2023 earnings

Q4 2023 earnings · · Investor relations

Briefing

TNGX Q4 2023 — extraction skipped

Tango Therapeutics Inc filed Form 8-K (accession 0000950170-24-032513) for Q4 2023, but headline financial numerics could not be extracted automatically: no headline numerics found by parser nor by Financial Datasets fallback. The row is marked as AI-processed so the queue advances; numerics will be filled by Financial Datasets on its next pass.

  • Form 8-K filed; press release body not parseable here.
  • Reason: no headline numerics found by parser nor by Financial Datasets fallback.
  • Numerics rely on the Financial Datasets fallback.

Headline financials

Total Revenue

$5.43M

Previous: $6.41M-15.3%
EPS (adj)

-$0.32

Previous: -$0.33+3.0%
Capital Expenditures

-$226K

Previous: $1.04M-121.7%
Net Income

-$30.8M

Previous: -$29.1M-5.9%
Operating Income

-$35M

Previous: -$30.6M-14.5%
Gross Profit

$4.81M

Previous: $6.41M-24.9%
R&D Expense

$31.3M

No prior period
Stock-Based Comp

$4.88M

Previous: $3.79M+28.9%

Revenue & EPS history

Tango Therapeutics · Revenue · Quarterly

$5.43M

Q4 2023-15.3%vs Q4 2022
Beat estimate in 6 of 13 quarters(46%)
ActualEstimate

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 18 quarterly earnings reports · overlaid with Q4 2023

Historical avgQ4 2023

+0.6%

Avg return

Earnings day

+6.7%

Avg return

5 days after

+25.8%

Avg return

30 days after

58%

11 / 19 earnings

Positive

+36.4%

Q4 2025

Best reaction

-45.4%

Q3 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+8.6%-12.1%+31.7%
Q4 2025+36.4%+33.6%+75.1%
Q3 2025+0.2%-1.7%+23.6%
Q1 2025+17.1%+31.6%+315.8%
Q4 2024-6.5%-21.0%-36.9%
Q3 2024-45.4%-34.7%-34.7%
Q2 2024-1.8%-5.7%+20.9%
Q1 2024-0.8%-6.9%-12.1%
Q4 2023-9.7%-14.4%-17.4%
Q3 2023+3.8%-12.1%+6.6%
Q2 2023+1.2%+120.9%+113.5%
Q1 2023+6.4%+4.4%-0.3%
Q4 2022-9.4%-5.3%-21.6%
Q3 2022-5.3%+6.7%-1.3%
Q2 2022+22.4%+32.8%-8.1%
Q1 2022-7.6%+1.2%-3.8%
Q4 2021+0.3%+6.8%+1.3%
Q3 2021+0.4%+5.2%-10.7%
Q2 2021+1.1%-2.2%+49.4%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro